In HER2-positive breast cancer patients on adjuvant trastuzumab (89 randomised, 76 with baseline data), NRG1 fell with 12 weeks of exercise (-0.20 ng/ml) but was stable in controls; baseline NRG1 was higher with exercise, and changes did not correlate with VO2 max or LVEF.
RCTn = 89
Jacquinot et al. Exercise training decreases Neuregulin-1 concentrations in HER2-positive breast cancer patients undergoing adjuvant trastuzumab: the CARDAPAC study